Karen Gelmon

32PUBLICATIONS
238CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPsychosocial aspects of childbirth and perinatal mental healthPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|May 26, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.

|Apr 27, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update).

|Feb 26, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Early Breast Cancer 2025.

Sandeep Sehdev, Anil Abraham Joy, Jean-François Boileau

|Feb 26, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Metastatic Breast Cancer 2025.

Katarzyna J Jerzak, Aalok Kumar, Jean-François Boileau

|Oct 22, 2025
Continuous versus Standard Palbociclib Treatment and Molecular Profiling of Solid Tissues and Liquid Biopsies in the CCTG MA.38 Trial in Advanced Breast Cancer.

Anil Abraham Joy, Nicholas Cheng, Karen A Gelmon

|Sep 02, 2025
Reply to: Germline and Somatic BRCA1/2 Mutations in Breast Cancer Treatment Strategies.

Eric Hahnen, Jan Hauke, Karen Gelmon

Pageof 6

Frequent Collaborators

7 joint publications

Sandeep Sehdev

7 joint publications

Nathalie LeVasseur

6 joint publications

Mita Manna

6 joint publications

Christine Brezden-Masley